Suppr超能文献

富血小板血浆疗法发展面临的挑战。

Current Challenges in the Development of Platelet-Rich Plasma-Based Therapies.

机构信息

Microfluidics Cluster UPV/EHU BIOMICs Microfluidics Group Lascaray Research Center University of the Basque Country UPV/EHU 01006, Vitoria-Gasteiz, Spain.

Advance Biological Therapy Unit Hospital Vithas Vitoria 01008, Vitoria-Gasteiz, Spain.

出版信息

Biomed Res Int. 2024 Aug 9;2024:6444120. doi: 10.1155/2024/6444120. eCollection 2024.

Abstract

Nowadays, biological therapies are booming and more of these formulations are coming to the market. Platelet-rich plasma, or PRP, is one of the most widely used biological therapies due to its ease of obtention and autologous character. Most of the techniques to obtain PRP are focusing on new processes and methods of optimization. However, not enough consideration is being given to modify the molecular components of PRP to generate more effective formulations with the aim of improving PRP treatments. Therefore, this review covers different novel PRP-obtaining methods that attempt to modify the molecular composition of the plasma.

摘要

如今,生物疗法正在蓬勃发展,越来越多的这类制剂正推向市场。由于易于获取和自体特性,富血小板血浆(PRP)是应用最广泛的生物疗法之一。大多数获取 PRP 的技术都集中在新的工艺和优化方法上。然而,对于修改 PRP 的分子成分以生成更有效的制剂以提高 PRP 治疗效果的关注还不够。因此,本综述涵盖了不同的新型 PRP 获取方法,这些方法试图修改血浆的分子组成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f07/11329313/c88c74f03b5e/BMRI2024-6444120.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验